Global Metamizole Sodium Injection 麻豆原创 Research Report 2025

Publication ID:

PB502253354

Publication Date:

February 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Metamizole Sodium Injection was valued at US$ 816 million in the year 2024 and is projected to reach a revised size of US$ 1034 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Metamizole Sodium Injection (also known as Dipyrone Sodium Injection) is a non-opioid analgesic and antipyretic used primarily for the management of severe pain and fever. It is an intravenous (IV) or intramuscular (IM) form of metamizole (also called dipyrone), a potent pain reliever commonly used in many parts of the world.
North American market for Metamizole Sodium Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Metamizole Sodium Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Metamizole Sodium Injection include AdvaCare Pharma, Sanofi, Novartis, Teva Pharmaceutical, Centurion Healthcare, Reyoung Pharma, Naman Pharma Drugs, Bhumi Pharmaceuticals, WAMIN, Montage Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Metamizole Sodium Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metamizole Sodium Injection.
The Metamizole Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metamizole Sodium Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metamizole Sodium Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AdvaCare Pharma
Sanofi
Novartis
Teva Pharmaceutical
Centurion Healthcare
Reyoung Pharma
Naman Pharma Drugs
Bhumi Pharmaceuticals
WAMIN
Montage Laboratories
Krosyl Pharmaceutical
Taj Life Sciences
Drag Pharma
MSD
Segment by Type
500mg/1ml
1000mg/2 ml
Segment by Application
Hospital
Research Institute
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metamizole Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metamizole Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Metamizole Sodium Injection 麻豆原创 Overview
1.1 Product Definition
1.2 Metamizole Sodium Injection by Type
1.2.1 Global Metamizole Sodium Injection 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 500mg/1ml
1.2.3 1000mg/2 ml
1.3 Metamizole Sodium Injection by Application
1.3.1 Global Metamizole Sodium Injection 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Research Institute
1.4 Global Metamizole Sodium Injection 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Metamizole Sodium Injection Revenue 2020-2031
1.4.2 Global Metamizole Sodium Injection Sales 2020-2031
1.4.3 Global Metamizole Sodium Injection 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Metamizole Sodium Injection 麻豆原创 Competition by Manufacturers
2.1 Global Metamizole Sodium Injection Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Metamizole Sodium Injection Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Metamizole Sodium Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Metamizole Sodium Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metamizole Sodium Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metamizole Sodium Injection, Product Type & Application
2.7 Global Key Manufacturers of Metamizole Sodium Injection, Date of Enter into This Industry
2.8 Global Metamizole Sodium Injection 麻豆原创 Competitive Situation and Trends
2.8.1 Global Metamizole Sodium Injection 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Metamizole Sodium Injection Players 麻豆原创 Share by Revenue
2.8.3 Global Metamizole Sodium Injection Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Metamizole Sodium Injection 麻豆原创 Scenario by Region
3.1 Global Metamizole Sodium Injection 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Metamizole Sodium Injection Sales by Region: 2020-2031
3.2.1 Global Metamizole Sodium Injection Sales by Region: 2020-2025
3.2.2 Global Metamizole Sodium Injection Sales by Region: 2026-2031
3.3 Global Metamizole Sodium Injection Revenue by Region: 2020-2031
3.3.1 Global Metamizole Sodium Injection Revenue by Region: 2020-2025
3.3.2 Global Metamizole Sodium Injection Revenue by Region: 2026-2031
3.4 North America Metamizole Sodium Injection 麻豆原创 Facts & Figures by Country
3.4.1 North America Metamizole Sodium Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Metamizole Sodium Injection Sales by Country (2020-2031)
3.4.3 North America Metamizole Sodium Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Metamizole Sodium Injection 麻豆原创 Facts & Figures by Country
3.5.1 Europe Metamizole Sodium Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Metamizole Sodium Injection Sales by Country (2020-2031)
3.5.3 Europe Metamizole Sodium Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metamizole Sodium Injection 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Metamizole Sodium Injection 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Metamizole Sodium Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Metamizole Sodium Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Metamizole Sodium Injection 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Metamizole Sodium Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Metamizole Sodium Injection Sales by Country (2020-2031)
3.7.3 Latin America Metamizole Sodium Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Metamizole Sodium Injection 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Metamizole Sodium Injection 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Metamizole Sodium Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Metamizole Sodium Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metamizole Sodium Injection Sales by Type (2020-2031)
4.1.1 Global Metamizole Sodium Injection Sales by Type (2020-2025)
4.1.2 Global Metamizole Sodium Injection Sales by Type (2026-2031)
4.1.3 Global Metamizole Sodium Injection Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Metamizole Sodium Injection Revenue by Type (2020-2031)
4.2.1 Global Metamizole Sodium Injection Revenue by Type (2020-2025)
4.2.2 Global Metamizole Sodium Injection Revenue by Type (2026-2031)
4.2.3 Global Metamizole Sodium Injection Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Metamizole Sodium Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Metamizole Sodium Injection Sales by Application (2020-2031)
5.1.1 Global Metamizole Sodium Injection Sales by Application (2020-2025)
5.1.2 Global Metamizole Sodium Injection Sales by Application (2026-2031)
5.1.3 Global Metamizole Sodium Injection Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Metamizole Sodium Injection Revenue by Application (2020-2031)
5.2.1 Global Metamizole Sodium Injection Revenue by Application (2020-2025)
5.2.2 Global Metamizole Sodium Injection Revenue by Application (2026-2031)
5.2.3 Global Metamizole Sodium Injection Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Metamizole Sodium Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AdvaCare Pharma
6.1.1 AdvaCare Pharma Company Information
6.1.2 AdvaCare Pharma Description and Business Overview
6.1.3 AdvaCare Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AdvaCare Pharma Metamizole Sodium Injection Product Portfolio
6.1.5 AdvaCare Pharma Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Metamizole Sodium Injection Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Metamizole Sodium Injection Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Teva Pharmaceutical
6.4.1 Teva Pharmaceutical Company Information
6.4.2 Teva Pharmaceutical Description and Business Overview
6.4.3 Teva Pharmaceutical Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Pharmaceutical Metamizole Sodium Injection Product Portfolio
6.4.5 Teva Pharmaceutical Recent Developments/Updates
6.5 Centurion Healthcare
6.5.1 Centurion Healthcare Company Information
6.5.2 Centurion Healthcare Description and Business Overview
6.5.3 Centurion Healthcare Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Centurion Healthcare Metamizole Sodium Injection Product Portfolio
6.5.5 Centurion Healthcare Recent Developments/Updates
6.6 Reyoung Pharma
6.6.1 Reyoung Pharma Company Information
6.6.2 Reyoung Pharma Description and Business Overview
6.6.3 Reyoung Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Reyoung Pharma Metamizole Sodium Injection Product Portfolio
6.6.5 Reyoung Pharma Recent Developments/Updates
6.7 Naman Pharma Drugs
6.7.1 Naman Pharma Drugs Company Information
6.7.2 Naman Pharma Drugs Description and Business Overview
6.7.3 Naman Pharma Drugs Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Naman Pharma Drugs Metamizole Sodium Injection Product Portfolio
6.7.5 Naman Pharma Drugs Recent Developments/Updates
6.8 Bhumi Pharmaceuticals
6.8.1 Bhumi Pharmaceuticals Company Information
6.8.2 Bhumi Pharmaceuticals Description and Business Overview
6.8.3 Bhumi Pharmaceuticals Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bhumi Pharmaceuticals Metamizole Sodium Injection Product Portfolio
6.8.5 Bhumi Pharmaceuticals Recent Developments/Updates
6.9 WAMIN
6.9.1 WAMIN Company Information
6.9.2 WAMIN Description and Business Overview
6.9.3 WAMIN Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 WAMIN Metamizole Sodium Injection Product Portfolio
6.9.5 WAMIN Recent Developments/Updates
6.10 Montage Laboratories
6.10.1 Montage Laboratories Company Information
6.10.2 Montage Laboratories Description and Business Overview
6.10.3 Montage Laboratories Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Montage Laboratories Metamizole Sodium Injection Product Portfolio
6.10.5 Montage Laboratories Recent Developments/Updates
6.11 Krosyl Pharmaceutical
6.11.1 Krosyl Pharmaceutical Company Information
6.11.2 Krosyl Pharmaceutical Description and Business Overview
6.11.3 Krosyl Pharmaceutical Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Krosyl Pharmaceutical Metamizole Sodium Injection Product Portfolio
6.11.5 Krosyl Pharmaceutical Recent Developments/Updates
6.12 Taj Life Sciences
6.12.1 Taj Life Sciences Company Information
6.12.2 Taj Life Sciences Description and Business Overview
6.12.3 Taj Life Sciences Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Taj Life Sciences Metamizole Sodium Injection Product Portfolio
6.12.5 Taj Life Sciences Recent Developments/Updates
6.13 Drag Pharma
6.13.1 Drag Pharma Company Information
6.13.2 Drag Pharma Description and Business Overview
6.13.3 Drag Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Drag Pharma Metamizole Sodium Injection Product Portfolio
6.13.5 Drag Pharma Recent Developments/Updates
6.14 MSD
6.14.1 MSD Company Information
6.14.2 MSD Description and Business Overview
6.14.3 MSD Metamizole Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MSD Metamizole Sodium Injection Product Portfolio
6.14.5 MSD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metamizole Sodium Injection Industry Chain Analysis
7.2 Metamizole Sodium Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metamizole Sodium Injection Production Mode & Process Analysis
7.4 Metamizole Sodium Injection Sales and 麻豆原创ing
7.4.1 Metamizole Sodium Injection Sales Channels
7.4.2 Metamizole Sodium Injection Distributors
7.5 Metamizole Sodium Injection Customer Analysis
8 Metamizole Sodium Injection 麻豆原创 Dynamics
8.1 Metamizole Sodium Injection Industry Trends
8.2 Metamizole Sodium Injection 麻豆原创 Drivers
8.3 Metamizole Sodium Injection 麻豆原创 Challenges
8.4 Metamizole Sodium Injection 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AdvaCare Pharma
Sanofi
Novartis
Teva Pharmaceutical
Centurion Healthcare
Reyoung Pharma
Naman Pharma Drugs
Bhumi Pharmaceuticals
WAMIN
Montage Laboratories
Krosyl Pharmaceutical
Taj Life Sciences
Drag Pharma
MSD

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.